Company profile

Swiss Bioscience GmbH

GMP pharmaceutical company for production and banking hADSC stem cells for individuals

Industry
Pharmaceutical Manufacturing
Employees
15
Headquarters
Schlieren, Zurich
Founded
2014
LinkedIn followers
555
Office locations
1

Swiss Bioscience GmbH company summary

Swiss Bioscience GmbH is a company in the Pharmaceutical Manufacturing industry, headquartered in Schlieren, Zurich, founded in 2014. On LinkedIn the company has around 15 employees and 555 followers.

What technology does Swiss Bioscience GmbH use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Swiss Bioscience GmbH

Swiss Bioscience GmbH was established in 2014 in Switzerland and is specialized in producing pharmaceutical quality grade stems cells under cGMP* conditions. The cells are isolated from human adipose tissue to produce stromal vascular fraction (SVF) which is then purified and expanded to produce human adipose tissue derived stem cells (hADSCs). Swiss Bioscience GmbH pursues research and development in the domain of stem cells, create new cell therapy based modalities for human medical use. Swiss Bioscience GmbH research program is based on utilisation of the paracrine effect of stem cells and is aimed at developing therapeutics from extracellular vesicles extracted from stem cells. hADSC and SVF may only be used as a transplant product within the framework of a valid marketing authorization or within the framework of controlled clinical studies.

Where is Swiss Bioscience GmbH located?

Swiss Bioscience GmbH lists 1 location.

Schlieren, Zurich, CHHQ
Wagisstrasse

Compare companies similar to Swiss Bioscience GmbH

More companies in Pharmaceutical Manufacturing.

CompanyIndustryEmployeesFoundedHeadquarters
Swiss Bioscience GmbH
swissbioscience.ch
Pharmaceutical Manufacturing152014Schlieren, Zurich
Pharmaceutical Manufacturing108,102-New York, New York
Sanofi
sanofi.com
Pharmaceutical Manufacturing93,352-Paris, France, FR
GSK
gsk.com
Pharmaceutical Manufacturing92,179-London, England
Novartis España
novartis.com
Pharmaceutical Manufacturing85,373-Basel, Baselstadt
AstraZeneca
astrazeneca.com
Pharmaceutical Manufacturing80,667-Cambridge, Cambridgeshire, GB
Pharmaceutical Manufacturing57,202-Indianapolis, Indiana
Merck
merck.us
Pharmaceutical Manufacturing44,794-Rahway, New Jersey
SUN PHARMA
sunpharma.com
Pharmaceutical Manufacturing47,7641983Mumbai, Maharastra
Boehringer Ingelheim
boehringer-ingelheim.com
Pharmaceutical Manufacturing47,150-Ingelheim am Rhein, Rhineland-Palatinate
Cipla
cipla.com
Pharmaceutical Manufacturing51,911-Mumbai, Maharashtra

Frequently asked questions about Swiss Bioscience GmbH

What does Swiss Bioscience GmbH do?

Swiss Bioscience GmbH was established in 2014 in Switzerland and is specialized in producing pharmaceutical quality grade stems cells under cGMP* conditions. The cells are isolated from human adipose tissue to produce stromal vascular fraction (SVF) which is then purified and expanded to produce human adipose tissue derived stem cells (hADSCs). Swiss Bioscience GmbH pursues research and development in the domain of stem cells, create new cell therapy based modalities for human medical use. Swiss Bioscience GmbH research program is based on utilisation of the paracrine effect of stem cells and is aimed at developing therapeutics from extracellular vesicles extracted from stem cells. hADSC and SVF may only be used as a transplant product within the framework of a valid marketing authorization or within the framework of controlled clinical studies.

How many employees does Swiss Bioscience GmbH have?

Swiss Bioscience GmbH has around 15 employees on LinkedIn.

Where is Swiss Bioscience GmbH headquartered?

Swiss Bioscience GmbH is headquartered in Schlieren, Zurich.

When was Swiss Bioscience GmbH founded?

Swiss Bioscience GmbH was founded in 2014.

Build a lead list from companies like Swiss Bioscience GmbH

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.